| Johnson K, Sargent LA, Galizio C, et al.
Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient. [Journal Article]
Eur J Gastroenterol Hepatol 2008 Nov; 20(11):1110-4.
Abstract | Full Citation | Find Related Articles | | Slama L, Le Camus C, Serfaty L, et al.
Metabolic disorders and chronic HIV and HCV infection. [JOURNAL ARTICLE]
Diabetes Metab 2008 Nov 27.
Abstract | Full Citation | | Laufer N, Laguno M, Perez I, et al.
Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Antivir Ther 2008; 13(7):953-7.
Abstract | Full Citation | Find Related Articles | | Shudo E, Ribeiro RM, Talal AH, et al.
A hepatitis C viral kinetic model that allows for time-varying drug effectiveness. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Antivir Ther 2008; 13(7):919-26.
Abstract | Full Citation | Find Related Articles | | Erickson AK, Seiwert S, Gale M
Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Antivir Ther 2008; 13(7):851-62.
Abstract | Full Citation | Find Related Articles | | Motegi E, Uesawa Y, Dai Y, et al.
Relationship between Patient Profile and Feverishness Developed during Interferon-Ribavirin Combination Therapy of Chronic Hepatitis C Patients. [Journal Article]
Yakugaku Zasshi 2008 Dec; 128(12):1803-10.
Abstract | Full Citation | | Lin CC, Yin MC
Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. [JOURNAL ARTICLE]
Clin Nutr 2008 Nov 28.
Abstract | Full Citation | | Kearney KR, Thornton JJ, Navarro VJ
Taribavirin for the treatment of chronic hepatitis C. [JOURNAL ARTICLE]
Expert Opin Pharmacother 2008 Dec; 9(18):3243-3249.
Abstract | Full Citation | | Njouom R, Sartre MT, Timba I, et al.
Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. [Journal Article]
J Med Virol 2008 Dec; 80(12):2079-85.
Abstract | Full Citation | Find Related Articles | | Litwin AH, Harris KA, Nahvi S, et al.
Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. [JOURNAL ARTICLE]
J Subst Abuse Treat 2008 Nov 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
